219 related articles for article (PubMed ID: 11475233)
1. [Hypoglycemic treatment of type 2 diabetes].
Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
Viberti G
J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
4. [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
Kishikawa H; Araki E; Wake N; Shichiri M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():140-5. PubMed ID: 12386985
[No Abstract] [Full Text] [Related]
5. [Combination therapy of oral antidiabetic drugs with insulin].
Lotz N; Bachmann W
Z Gesamte Inn Med; 1993 Mar; 48(3):130-4. PubMed ID: 8475636
[TBL] [Abstract][Full Text] [Related]
6. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
Tanenberg RJ
Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
[TBL] [Abstract][Full Text] [Related]
7. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
8. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
9. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
Campbell IW
Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
[TBL] [Abstract][Full Text] [Related]
10. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
11. Treatment of type II diabetes: what options have been added to traditional methods?
Cefalu WT
Postgrad Med; 1996 Mar; 99(3):109-19, 122. PubMed ID: 8637824
[TBL] [Abstract][Full Text] [Related]
12. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
13. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies in type 2 diabetes].
Waeber G; Vollenweider P; Ruiz J
Praxis (Bern 1994); 2001 Dec; 90(51-52):2245-54. PubMed ID: 11820166
[TBL] [Abstract][Full Text] [Related]
15. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of diabetic patients with respect to prevention of macrovascular disease.
Tkác T
Acta Diabetol; 2003 Dec; 40 Suppl 2():S338-42. PubMed ID: 14704865
[TBL] [Abstract][Full Text] [Related]
17. [The effect of diabetic treatment on the development and progression of diabetic complications].
Nakai T
Nihon Rinsho; 1997 Nov; 55 Suppl():711-20. PubMed ID: 9434553
[No Abstract] [Full Text] [Related]
18. [Objectives and therapeutic strategy in type 2 diabetes mellitus].
Calvo Romero JM; Lima Rodríguez EM
An Med Interna; 2001 Jul; 18(7):381-8. PubMed ID: 11534426
[TBL] [Abstract][Full Text] [Related]
19. Glucose control in diabetes.
Valeri C; Pozzilli P; Leslie D
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S1-8. PubMed ID: 15551299
[TBL] [Abstract][Full Text] [Related]
20. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
